About
David Younger is the Co-Founder and CEO of A-Alpha Bio, a Seattle-based biotechnology company applying synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions for therapeutic development and pharmaceutical partnerships. He is a co-inventor of the company's AlphaSeq platform, which quantifies large numbers of protein-protein interactions to train predictive models used in the discovery of therapeutic antibodies and molecular glues. Younger holds a PhD in Bioengineering from the University of Washington, where he was advised by David Baker and Eric Klavins.
Founder at A-Alpha Bio
Intro paths
→
In turn, David can intro founders to A-Alpha Bio's investors below.
A-Alpha Bio's investors · 8
Angel Collective Opportunity FundSan FranciscoBoom Capital VenturesSan Francisco · $50K – $300K checksBreakout VenturesSan Francisco · $500K – $6M checksFarvatn VentureBergenLux CapitalNew York · $100K – $100M checksMadrona Venture GroupSeattle · $2M – $10M checks · since 2021National Science FoundationAlexandria · since 2018OS FundPark Ridge · $1M – $2M checks
Co-founders at A-Alpha Bio
DY
David Younger, PhDChief Executive Officer & Co-Founder
RL
Randolph Lopez, PhDChief Technology Officer & Co-Founder
RL
Randolph LopezFounder
Experience
- A-Alpha BioCo-Founder and CEOcurrent2017 — presentSeattle, Washington, United States
- University of WashingtonPostdoctoral Researcher2017 — 2018Seattle, Washington, United States
- University of WashingtonBioengineering Graduate Student2012 — 2017Seattle, WA
- Luminex CorporationEngineering Intern2011Austin, Texas Metropolitan Area
- Seattle Biomedical Research InstituteIntern2007Greater Seattle Area
Skills & more
FundraisingStartupsBusiness StrategyMolecular Biology5Synthetic Biology3Business Development2Assay Development2Data Analysis3Genetics1Cell Culture5Genomics1Flow Cytometry
+8 more
Coaching & MentoringDNA SequencingProtein EngineeringGrant WritingLeadershipMatlabMicrosoft PowerPointPythonFrom David's professional profile.
Frequently asked questions
- Who is David Younger?
- David Younger is the Co-Founder and CEO of A-Alpha Bio, a Seattle-based biotechnology company applying synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions for therapeutic development and pharmaceutical partnerships. He is a co-inventor of the company's AlphaSeq platform, which quantifies large numbers of protein-protein interactions to train predictive models used in the discovery of therapeutic antibodies and molecular glues. Younger holds a PhD in Bioengineering from the University of Washington, where he was advised by David Baker and Eric Klavins.
- Where does David Younger work?
- David Younger is Founder of A-Alpha Bio.
- What companies did David Younger found?
- David Younger founded A-Alpha Bio.
- Where did David Younger go to school?
- David Younger studied at University of Washington (Doctor of Philosophy (PhD), Bioengineering); Rice University (Bachelor of Science; Bachelor of Arts, Bioengineering); The London School of Economics and Political Science (LSE) (Economics).
Founder mafias
The London School of Economics and Political Science (LSE) mafia225
Also came through, then founded or led a company.
Anne OsdoitCorporate Finance & Strategy - Executive summer schoolFounded Moon Surgical +2Toby TriebelBsCFounded Spotcap +1Shaoib MakaniBScFounded Motive Technologies +1Steve LoughlinCertificateFounded RelateIQ +1James J BesharaDevelopment Economics and International DevelopmentFounded Tilt +1Kyle MichelsonGovernment & GlobalizationFounded Getlabs +1
+ 218 more
University of Washington mafia165
Also came through, then founded or led a company.
Arvind JainMastersFounded Glean +2Jane MooneyBachelor of Business Administration - BBAFounded Collaborative RoboticsMatthew ScholzBSFounded Oisin Biotechnologies +3Emmett ShearFounded Softmax +2John WuPh.D.Founded Avalanche +2Rand FishkinNoneFounded SparkToro +2
+ 158 more
Rice University mafia70
Also came through, then founded or led a company.
Brian ArmstrongBachelor’s DegreeFounded Coinbase +1Dan WallaceBSMEFounded Versa Vascular +2Chris GibsonBachelor of Arts (B.A.)Founded Recursion (NASDAQ: RXRX) +1Web SmithStudy: RussianFounded Mizzen+Main +1Jonathan BehrB.S.Founded Tilos Therapeutics +1Jeffrey DietrichBSFounded Rarebird +1
+ 63 more
Same school
Also attended University of Washington377
Andrew ChenGeneral Partner at Andreessen HorowitzArvind JainFounder & CEO of GleanJane MooneyCo-founder & VP, Strategy and Finance at Collaborative RoboticsVictoria TreygerGeneral Partner at Felicis VenturesAndrewAdvisor at Clear VenturesJoe HorsmanInvestor at Madrona Venture Group
+ 371 more
Also attended Rice University185
Brian ArmstrongCo-founder & CEO of CoinbaseAbigail JohnsonPartner, Chief Operating Officer at Sapphire VenturesEdi DanalacheSenior Associate at Scale Venture PartnersJim BridenstineManaging Partner, Artemis Group at Cortado VenturesNicolette HoffmannSenior Associate at JMI EquityPatrick OkoraforDirector of Finance at Mercury Fund
+ 179 more
Also attended The London School of Economics and Political Science (LSE)1,376
Lee FixelFounder of AdditionPat GradyPartner at Sequoia CapitalNeil MehtaCo-founder & Managing Partner at GreenoaksCyriac ParisotInvestor at Index VenturesSofia DolfeInvestor at Index VenturesJonas VetterleInvestor at Moonfire Ventures
+ 1,370 more
Shared employers
Also worked at A-Alpha Bio3
Also worked at University of Washington128
Joe HorsmanInvestor at Madrona Venture GroupMike FridgenVenture Partner at Madrona Venture GroupSid ShenaiVenture partner at Madrona and co-founder and CEO of Proof DiagnosticsPaul JennyBoard Chair at CincyTechJason PrestonInvestor at Alsop Louie PartnersElliot HershbergScientist, Writer, and Investor on a mission to accelerate The Century of Biology
+ 122 more
